NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Scopio Labs

Scopio Labs

Private
Tel AvivHealthcare & Life Scienceshttps://scopiolabs.com/

Last Round

Series D

Extension

Jul 24, 2025

Total Funding Raised

$159M

Company Overview

Scopio Labs is a health tech company that develops full-field digital cell morphology imaging and analysis platforms to digitize hematology and blood cell morphology analysis.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Medical Imaging

Business Model

B2B

Customer Profile

Hardware Sales, Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

digital microscopyhematologytele-hematologyblood smear analysismedical AIdigital pathologydecision support systemDSSlaboratory information systemLISautomated diagnosticsremote lab analysisAI-powered diagnosticsclinical workflow automationmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Scopio Labs Comps

Public and private peers based on sector, stage, and business model.

Scopio Labs comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Scopio Labs Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series D ExtensionJul 24, 2025
Series DJul 24, 2024
DebtSep 28, 2022
Series CFeb 9, 2022
Series BApr 28, 2020
Series A
May 21, 2019

Key People

Founding team and executive leadership

Itai Hayut

Co-founder And CEO

Founding Team

Yossi Maimon

Chief Financial Officer

Executive Team

Amir Shlomovich

COO

Executive Team

Scopio Labs Investors

Notable investors and investment history

Scopio Labs investors
InvestorRounds
Kreos CapitalDebt
Aurum VenturesSeries B, Series C, Series A
Lumir VenturesSeries C
Entrée CapitalSeed
OTVSeed, Series C, Series B
Vertex Ventures IsraelSeed
Mivtach Shamir HoldingsSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 10, 2026

    Full-Field Peripheral Blood Smear Application receives FDA clearance.

  • Jan 1, 2026

    Full-Field Peripheral Blood Smear Application cleared by the FDA.

Scopio Labs Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Scopio Labs Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Scopio Labs's valuation, stock price, and market status.

Firmographic Details

HeadquartersTel Aviv
Employee Range164
Year Founded2015
Last FundingJul 24, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.